Xenon Pharmaceuticals Balance Sheet (2013-2026) | XENE

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Accumulated Depreciation (Quarter)			13.35M				8.71M				11.25M				13.46M				15.45M
Assets
Current Assets
Cash & Equivalents (Quarter)	82.93M	87.81M	175.69M	116.54M	369.99M	103.49M	57.24M	69.51M	64.55M	99.57M	148.64M	58.90M	136.73M	87.62M	142.71M	116.66M	135.38M	555.26M	199.16M	545.87M
Receivables - Net (Quarter)	2.92M	3.23M	2.77M	2.92M	2.52M	2.48M	0.99M	2.22M	2.12M	0.81M	0.87M	0.83M	0.85M	0.94M	1.47M	8.65M
Receivables - Other (Quarter)															1.47M		1.10M	0.81M	1.37M	1.17M
Receivables (Quarter)	2.92M	3.23M	2.77M	2.92M	2.52M	2.48M	0.99M	2.22M	2.12M	0.81M	0.87M	0.83M	0.85M	0.94M	2.94M	8.65M
Prepaid Assets (Quarter)	3.31M	3.45M	4.48M	4.75M	4.04M	8.51M	7.22M	4.09M	2.89M	3.53M	6.01M	6.77M	5.70M	4.69M	6.89M	7.26M	11.61M	17.06M	10.39M	10.72M
Current Assets (Quarter)	266.75M	256.31M	559.02M	545.62M	794.80M	649.18M	600.30M	533.35M	544.62M	531.01M	644.96M	707.20M	728.09M	659.64M	635.26M	565.54M	500.25M	480.14M	560.65M	1,106.63M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	4.33M	4.26M	4.47M	4.34M	4.54M	4.58M	6.50M	7.97M	9.56M	10.24M	9.65M	9.39M	10.14M	10.16M	10.28M	9.70M	9.21M	8.89M	8.72M	8.29M
Long-Term Investments (Quarter)						113.99M	128.68M	160.26M	112.59M	112.41M	292.79M	185.84M	129.06M	149.32M	127.50M	141.50M	137.30M	92.99M	37.15M	244.87M
Long-Term Deferred Tax (Quarter)	0.54M	0.81M	0.47M	0.21M	0.31M	0.51M	0.51M	0.22M	0.45M	0.60M	0.80M	0.40M	0.73M	1.05M	9.67M	10.88M	11.05M	11.75M	12.86M	12.42M
Other Non-Current Assets (Quarter)							7.75M	7.96M	7.88M	7.34M	7.40M	7.31M	7.42M	7.47M	7.50M	8.05M	9.19M	7.11M	7.15M	8.30M
Non-Current Assets (Quarter)	7.96M	8.04M	12.99M	12.44M	12.58M	126.64M	153.85M	186.52M	140.28M	140.09M	319.84M	211.82M	155.92M	176.26M	162.88M	177.74M	174.03M	127.70M	72.51M	280.18M
Assets (Quarter)	274.71M	264.35M	572.01M	558.06M	807.38M	775.81M	754.15M	719.87M	684.90M	671.09M	964.80M	919.02M	884.01M	835.90M	798.14M	743.28M	674.28M	607.84M	633.16M	1,386.81M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	3.28M	9.97M	13.72M	1.66M	13.74M	3.08M	8.49M	21.30M	12.03M	6.10M	25.97M	20.90M	29.93M	5.42M	5.07M	30.65M	31.59M	36.84M	3.88M	5.75M
Payables (Quarter)	3.28M	9.97M	13.72M	1.66M	13.74M	3.08M	8.49M	21.30M	12.03M	6.10M	25.97M	20.90M	29.93M	5.42M	5.07M	30.65M	31.59M	36.84M	3.88M	5.75M
Accumulated Expenses (Quarter)	2.46M	3.38M	5.94M	2.11M	3.32M	4.22M	5.82M	2.67M	4.92M	5.85M	7.42M	3.82M	6.20M	8.94M	12.06M	10.14M	15.25M	11.10M	36.38M	32.51M
Other Accumulated Expenses (Quarter)	0.07M	0.03M	0.12M	0.28M	0.24M	0.04M	0.34M	0.76M	0.09M	0.11M		0.11M	1.10M	1.08M	0.71M	0.45M	0.44M	0.94M	0.97M
Short term Debt (Quarter)
Current Leases (Quarter)	0.76M	0.69M	0.60M				0.49M	1.19M	1.22M	1.25M	1.30M	1.32M	1.35M	1.39M	1.37M	1.38M	1.46M	1.50M	1.53M	1.56M
Current Taxes (Quarter)											0.35M				5.69M	6.56M	1.83M	0.23M	0.31M
Current Deferred Revenue (Quarter)	3.02M	2.20M
Total Current Liabilities (Quarter)	14.98M	12.86M	14.32M	7.98M	13.74M	15.54M	22.70M	22.49M	28.16M	24.74M	27.27M	22.22M	31.29M	29.70M	35.59M	32.03M	33.05M	38.34M	41.79M	39.81M
Non-Current Liabilities
Non-Current Debt (Quarter)
Non-Current Deffered Revenue (Quarter)
Operating Leases (Quarter)	2.75M	2.56M	7.65M	8.22M	7.85M	7.16M	9.95M	10.43M	10.28M	9.76M	9.60M	9.10M	8.68M	8.40M	7.65M	7.29M	7.26M	6.83M	6.41M	5.93M
Other Non-Current Liabilities (Quarter)																		3.16M	3.20M	3.25M
Total Non-Current Liabilities (Quarter)															43.24M			45.17M	48.20M	45.74M
Total Liabilities (Quarter)	17.73M	15.41M	21.97M	16.21M	21.59M	22.69M	32.65M	32.92M	38.44M	34.50M	36.88M	31.32M	39.96M	38.09M	43.24M	39.32M	40.30M	48.33M	51.40M	48.99M
Shareholder's Equity
Total Debt (Quarter)
Common Equity (Quarter)	256.98M	248.94M	550.03M	541.85M	785.79M	753.12M	721.50M	686.94M	646.46M	636.59M	927.92M	887.70M	844.05M	797.81M	754.90M	703.96M	633.98M	559.51M	581.76M	1,337.82M
Shareholder's Equity (Quarter)	256.98M	248.94M	550.03M	541.85M	785.79M	753.12M	721.50M	686.94M	646.46M	636.59M	927.92M	887.70M	844.05M	797.81M	754.90M	703.96M	633.98M	559.51M	581.76M	1,337.82M
Liabilities and Shareholders Equity (Quarter)	274.71M	264.35M	572.01M	558.06M	807.38M	775.81M	754.15M	719.87M	684.90M	671.09M	964.80M	919.02M	884.01M	835.90M	798.14M	743.28M	674.28M	607.84M	633.16M	1,386.81M
Retained Earnings (Quarter)	-0.99M	-331.81M	-357.37M	-0.99M	-0.99M	-445.35M	-482.75M	-524.47M	-571.93M	-620.40M	-665.14M	-713.07M	-771.00M	-833.78M	-1.61M	-0.84M	-1049.22M	-1140.12M	-1245.38M	-1347.68M
Preferred Shares (Quarter)	7.73M	7.73M	7.73M
Treasury Shares (Quarter)												0.19M	0.20M	0.21M	0.21M	0.30M	0.28M	0.26M	0.35M	0.67M
Shares Outstanding (Quarter)	1.02M	1.02M	51.63M	53.06M	62.24M	62.54M	62.59M	63.11M	63.72M	65.00M	75.37M	75.46M	75.67M	75.79M	76.42M	76.59M	76.94M	77.12M	80.01M	96.62M

Research Tools

Developers

Xenon Pharmaceuticals Balance Sheet (2013-2026) | XENE

Research Tools

Developers

Xenon Pharmaceuticals Balance Sheet (2013-2026) | XENE

Create an account

Sign In

Reset Password